Committee reviews draft opioid settlement bill, keeps syringe services and sustainability rules in place

Unidentified Legislative Committee · February 13, 2026

Get AI-powered insights, summaries, and transcripts

Subscribe
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Lawmakers reviewed draft 4.1 of an opioid settlement bill that would appropriate funds from the Opioid Abatement Special Fund for syringe services, outreach staff, recovery residences and peer recovery coaches, add a sustainability-plan requirement for applicants, and pause new proposals in FY2028 except for four annually funded areas.

A legislative committee reviewed draft 4.1 of an opioid settlement bill on Feb. 14, examining line-by-line appropriations from the Opioid Abatement Special Fund and adding new rules for the advisory council that oversees grant decisions.

Katie, a legislative staff member who read the draft to the panel, said Section 1 would appropriate funds including $455,000 to the Department of Health for 26 outreach or case-management positions, $1,600,000 for recovery residences certified by VITAR, $850,000 for syringe services, and $1,100,000 to the Department of Corrections to fund peer recovery coaches in correctional facilities and probation and parole offices. Katie also read funding for a pre-hospital EMS buprenorphine training and treatment expansion (draft transcript reads "7.248000"), $35,000 for subsidized room and board at Rutland Mental Health Services’ transitional housing program, and roughly $237,646 for public safety liaison/team coordinator positions in several towns to support facilitation, data tracking and outreach.

The committee debated how to target recovery residence funding. Several members said they want at least $900,000 of the recovery-residence allocation directed toward NAR level-3 (or higher) beds to address capacity gaps; another group cautioned against locking the entire allocation to level-3-only beds and supported reserving $300,000 for geographically targeted new beds. "We want at least 900 of it to go to the level 3 or higher," said Speaker 1, reflecting that emphasis.

Members also discussed the status of prior-year obligations for syringe services. Speaker 3 said a "significant amount" of money in that funding bucket has been obligated to programs but not yet disbursed, and urged including the $850,000 in the bill "that way they do have access." The committee agreed to keep syringe services in the draft so providers would be eligible for the funding, while acknowledging the health department still needed to clarify exactly which portions of existing funds had been allocated versus distributed.

New committee language would amend the Opioid Settlement Advisory Committee charge to require each funding proposal to include a sustainability plan from applicants that explains future expenses and available resources. Members clarified the requirement should apply to ongoing funding proposals (not one-time startup grants) and discussed whether the sustainability plan must consider resources outside the opioid settlement fund; they agreed the intent was to require sustainability planning for ongoing proposals and to exempt the settlement fund itself as a funding source in some circumstances.

Katie also read a proposed one-year suspension in Section 6 that would prevent the advisory council from accepting new proposals in fiscal year 2028 so it could review outcomes of previously funded programs for effectiveness and long-term sustainability. Speaker 1 said the committee would add an explicit exception for the four areas the legislature had committed to annual funding (outreach/case management staff, recovery residences, syringe services and overdose prevention centers).

Committee members pressed the advisory council’s role in setting outcome measures and reporting: Speaker 3 said the committee had previously discussed requiring reports after six months and one year and urged the council to develop protocols to measure program outcomes. Other members raised process concerns about placing prevention projects in both the opioid bill and the main budget to ensure visibility, noting that numbers could change if they are amended in only one of the duplicate locations.

The draft will be edited into a clean version by legislative staff and returned for consideration; the committee plans to hear witnesses after 1 p.m. and vote on the bill that afternoon. The advisory committee changes and the FY2028 pause were discussed but no final vote on the draft occurred during this session.

Clarifying details and transcript inconsistencies: the transcript contains repeated or slightly different figures in one read-through (for example, liaison positions are read as $237,646 in multiple segments but one read contains $237,006); the EMS buprenorphine line is read as "7.248000" in the draft and requires confirmation from the published bill text or staff edits before publication. Where figures in the transcript were unclear, this article notes that the draft as read contains those numbers and identifies them for verification.

What comes next: staff will produce a clean draft reflecting the committee’s edits and the body will take testimony after 1 p.m. before a planned afternoon vote. If additional changes are made in the clean draft, committee members said they expect the Appropriations process to review any differences during bill amending.